The role of T cells in fighting cancer

by CU Anschutz Medical CampusCredit: CC0 Public DomainNew research from CU Cancer Center member Jing Hong Wang, MD, Ph.D., and recent University of Colorado Immunology program graduate Rachel Woo

Updated on: April 24,2024

The role of T cells in fighting cancer

by CU Anschutz Medical CampusCredit: CC0 Public DomainNew research from CU Cancer Center member Jing Hong Wang, MD, Ph.D., and recent University of Colorado Immunology program graduate Rachel Woo

Updated on:April 24,2024

Review highlights the challenges and recent advances in targeted therapies for lupus nephritis

by Cactus CommunicationsSLE involves abnormal activation of both innate and adaptive immune responses, leading to systemic immune dysregulation and renal impairment. The complement system's dysfun

Updated on: January 26,2024

Review highlights the challenges and recent advances in targeted therapies for lupus nephritis

by Cactus CommunicationsSLE involves abnormal activation of both innate and adaptive immune responses, leading to systemic immune dysregulation and renal impairment. The complement system's dysfun

Updated on:January 26,2024

Biological agent trials for psoriasis rarely include patient images

by Elana GotkineFew randomized controlled trials involving biological agents for psoriasis treatment include patient images, according to a review published online on Nov. 15 in theJournal of De

Updated on: January 28,2024

Biological agent trials for psoriasis rarely include patient images

by Elana GotkineFew randomized controlled trials involving biological agents for psoriasis treatment include patient images, according to a review published online on Nov. 15 in theJournal of De

Updated on:January 28,2024

COVID-19 immunity may last six months or more

by Meghan Rosen,Howard Hughes Medical InstituteScientists found traces of SARS-CoV-2 (green) in cells lining people’s intestines three months after infection. Antibodies may evolve in response t

Updated on: April 10,2024

COVID-19 immunity may last six months or more

by Meghan Rosen,Howard Hughes Medical InstituteScientists found traces of SARS-CoV-2 (green) in cells lining people’s intestines three months after infection. Antibodies may evolve in response t

Updated on:April 10,2024

App tackles problem of 'glue ear' in children

by Alex Earnshaw,Aston UniversityAston University is tackling the problem of 'glue ear' in children with a free* hearing test app for any concerned families.The main cause of temporary c

Updated on: March 02,2024

App tackles problem of 'glue ear' in children

by Alex Earnshaw,Aston UniversityAston University is tackling the problem of 'glue ear' in children with a free* hearing test app for any concerned families.The main cause of temporary c

Updated on:March 02,2024

Trial data underpins FDA approval of omalizumab for food allergy

by NIH/National Institute of Allergy and Infectious DiseasesCredit: Unsplash/CC0 Public DomainToday's Food and Drug Administration approval of a supplemental biologics license for the monoclo

Updated on: May 07,2024

Trial data underpins FDA approval of omalizumab for food allergy

by NIH/National Institute of Allergy and Infectious DiseasesCredit: Unsplash/CC0 Public DomainToday's Food and Drug Administration approval of a supplemental biologics license for the monoclo

Updated on:May 07,2024

VOYAGE phase 3: Dupilumab significantly reduced asthma exacerbations in children age 6-11

byAmerican Thoracic SocietyCredit: CC0 Public DomainResults from the VOYAGE study of dupilumab (Dupixent) showed that the monoclonal antibody significantly reduced exacerbations in children ages

Updated on: March 02,2024

VOYAGE phase 3: Dupilumab significantly reduced asthma exacerbations in children age 6-11

byAmerican Thoracic SocietyCredit: CC0 Public DomainResults from the VOYAGE study of dupilumab (Dupixent) showed that the monoclonal antibody significantly reduced exacerbations in children ages

Updated on:March 02,2024

The double face of RNase as a treatment for systemic autoimmune diseases

by Osaka UniversityThe RNA-degrading enzyme enhances the function of immune complexes formed by autoantibodies against Ro/SSA and La/SSB antigens. Credit: Ryota Naito et al. JCI Insight 2023Syste

Updated on: April 22,2024

The double face of RNase as a treatment for systemic autoimmune diseases

by Osaka UniversityThe RNA-degrading enzyme enhances the function of immune complexes formed by autoantibodies against Ro/SSA and La/SSB antigens. Credit: Ryota Naito et al. JCI Insight 2023Syste

Updated on:April 22,2024

Study pinpoints optimal timing for RSV vaccine during pregnancy

Updated on: November 14,2024

Study pinpoints optimal timing for RSV vaccine during pregnancy

Updated on:November 14,2024

Medication used to control blood sugar in people with type 2 diabetes may also reduce risk of autoimmune diseases

by American College of RheumatologyDipeptidyl peptidase-4 inhibitors commonly used to control blood sugar levels in people with type 2 diabetes may also reduce the risk of autoimmune diseases in these

Updated on: April 07,2024

Medication used to control blood sugar in people with type 2 diabetes may also reduce risk of autoimmune diseases

by American College of RheumatologyDipeptidyl peptidase-4 inhibitors commonly used to control blood sugar levels in people with type 2 diabetes may also reduce the risk of autoimmune diseases in these

Updated on:April 07,2024

Osteoarthritis biomarker could help cut $23 billion health bill

by Candy Gibson,University of South AustraliaCredit: Pixabay/CC0 Public DomainUniversity of South Australia researchers are a step closer to finding a new biomarker for osteoarthritis, a painful

Updated on: May 13,2024

Osteoarthritis biomarker could help cut $23 billion health bill

by Candy Gibson,University of South AustraliaCredit: Pixabay/CC0 Public DomainUniversity of South Australia researchers are a step closer to finding a new biomarker for osteoarthritis, a painful

Updated on:May 13,2024

Study reveals way to predict side-effect risk from common immune suppressant medication

by University of NottinghamMethotrexate (MTX) is an anti-metabolite most commonly used in chemotherapy and immunosuppressant in auto-immune diseases. Credit: University of NottinghamA major new s

Updated on: January 29,2024

Study reveals way to predict side-effect risk from common immune suppressant medication

by University of NottinghamMethotrexate (MTX) is an anti-metabolite most commonly used in chemotherapy and immunosuppressant in auto-immune diseases. Credit: University of NottinghamA major new s

Updated on:January 29,2024